Physician profile
Scott D Kaiser
NPI 1093799215
$815.78
in general payments reported to CMS, 2019-2025
20 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.12 · 2022: $52.89 · 2023: $251 · 2024: $227 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.66 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $137.01 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $124.80 | 2025 | Airsupra |
| Inspire Medical Systems, INC. | $102.24 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $70.36 | 2023-2025 | Bexsero, Arexvy, Shingrix |
| Phadia US INC. | $45.97 | 2023-2025 | Immunocap |
| Abbvie INC. | $45.00 | 2022-2025 | |
| Medtronic, INC. | $41.51 | 2021-2025 | Symplicity G3 |
| Edwards Lifesciences Corporation | $33.12 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi Pasteur INC. | $28.65 | 2024 | |
| Lucid Diagnostics INC. | $28.31 | 2022-2024 | |
| Hologic Sales and Service, LLC | $26.06 | 2024 | Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $25.56 | 2021-2024 | Vaxelis, Gardasil 9, Capvaxive |
| Dexcom, INC. | $23.19 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $17.17 | 2024 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $14.42 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.38 | 2023 | Austedo Xr |
| Lilly USA, LLC | $11.71 | 2022 | |
| Organon LLC | $11.21 | 2025 | Nexplanon |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.